• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Options for states to constrain pricing power of health care providers.各州限制医疗服务提供者定价权的方式。
Front Health Serv. 2022 Oct 19;2:1020920. doi: 10.3389/frhs.2022.1020920. eCollection 2022.
2
Do State Bans of Most-Favored-Nation Contract Clauses Restrain Price Growth? Evidence From Hospital Prices.州政府是否禁止最惠国待遇合同条款来限制价格增长?来自医院价格的证据。
Milbank Q. 2022 Jun;100(2):589-615. doi: 10.1111/1468-0009.12568. Epub 2022 May 10.
3
Hospital pricing: cost shifting and competition.医院定价:成本转嫁与竞争。
EBRI Issue Brief. 1993 May(137):1-17.
4
5
Environmental Scan on Consolidation Trends and Impacts in Health Care Markets.医疗保健市场整合趋势与影响的环境扫描
Rand Health Q. 2023 Jun 16;10(3):2. eCollection 2023 Jun.
6
7
Addressing health care market reform through an insurance exchange: essential policy components, the public plan option, and other issues to consider.通过保险交易所推进医疗保健市场改革:基本政策要素、公共计划选项及其他需考虑的问题。
EBRI Issue Brief. 2009 Jun(330):1-22.
8
Market Share Matters: Evidence Of Insurer And Provider Bargaining Over Prices.市场份额至关重要:保险公司与医疗服务提供商就价格进行讨价还价的证据。
Health Aff (Millwood). 2017 Jan 1;36(1):141-148. doi: 10.1377/hlthaff.2016.0479.
9
The future of Cochrane Neonatal.考克兰新生儿协作网的未来。
Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12.
10
The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.美国处方药价格居高不下:根源与改革前景。
JAMA. 2016;316(8):858-71. doi: 10.1001/jama.2016.11237.

引用本文的文献

1
Considerations for state-imposed conditions on healthcare provider transactions.关于国家对医疗服务提供者交易施加条件的考量。
Front Public Health. 2023 Aug 16;11:1220624. doi: 10.3389/fpubh.2023.1220624. eCollection 2023.

本文引用的文献

1
Prices Paid to Hospitals by Private Health Plans: Findings from Round 4 of an Employer-Led Transparency Initiative.私人健康保险计划向医院支付的费用:雇主主导的透明度倡议第四轮调查结果
Rand Health Q. 2022 Nov 14;10(1):5. eCollection 2022 Nov.
2
Medicare Advantage for All, Perhaps?
JAMA Health Forum. 2020 Jul 1;1(7):e200967. doi: 10.1001/jamahealthforum.2020.0967.
3
Concordance of Hospital Ranks and Category Ratings Using the Current Technical Specification of US Hospital Star Ratings and Reasonable Alternative Specifications.使用美国医院星级评定现行技术规范和合理替代规范的医院等级和类别评级的一致性。
JAMA Health Forum. 2022 May 13;3(5):e221006. doi: 10.1001/jamahealthforum.2022.1006. eCollection 2022 May.
4
How Price Regulation Is Needed To Advance Market Competition.需要价格监管来推进市场竞争。
Health Aff (Millwood). 2022 Jan;41(1):26-34. doi: 10.1377/hlthaff.2021.01235.
5
National Health Care Spending In 2020: Growth Driven By Federal Spending In Response To The COVID-19 Pandemic.2020 年国家医疗保健支出:联邦支出因应对 COVID-19 大流行而增长。
Health Aff (Millwood). 2022 Jan;41(1):13-25. doi: 10.1377/hlthaff.2021.01763. Epub 2021 Dec 15.
6
Coding-Driven Changes In Measured Risk In Accountable Care Organizations.编码驱动的问责制医疗组织中测量风险的变化。
Health Aff (Millwood). 2021 Dec;40(12):1909-1917. doi: 10.1377/hlthaff.2021.00361.
7
Participation, Pricing, and Enrollment in a Health Insurance "Public Option": Evidence From Washington State's Cascade Care Program.参与、定价和参加健康保险“公共选择”:华盛顿州 Cascades Care 计划的证据。
Milbank Q. 2022 Mar;100(1):190-217. doi: 10.1111/1468-0009.12546. Epub 2021 Nov 23.
8
State Public Option Plans - Too Modest to Improve Affordability?州公共选择计划——力度太小不足以提高可承受性?
N Engl J Med. 2021 Sep 16;385(12):1057-1059. doi: 10.1056/NEJMp2111356. Epub 2021 Sep 11.
9
Association of Surprise-Billing Legislation with Prices Paid to In-Network and Out-of-Network Anesthesiologists in California, Florida, and New York: An Economic Analysis.加利福尼亚州、佛罗里达州和纽约州意外账单立法与支付给网络内和网络外麻醉医师的价格之间的关联:一项经济分析
JAMA Intern Med. 2021 Oct 1;181(10):1324-1331. doi: 10.1001/jamainternmed.2021.4564.
10
Geographic Variation In The Consolidation Of Physicians Into Health Systems, 2016-18.2016-2018 年,医生整合入医疗体系的地域差异。
Health Aff (Millwood). 2021 Jan;40(1):165-169. doi: 10.1377/hlthaff.2020.00812.

各州限制医疗服务提供者定价权的方式。

Options for states to constrain pricing power of health care providers.

作者信息

Gudiksen Katherine L, Murray Robert B

机构信息

The Source on Healthcare Price and Competition, University of Hastings College of the Law, San Francisco, CA, United States.

Global Health Payment LLC, Towson, MD, United States.

出版信息

Front Health Serv. 2022 Oct 19;2:1020920. doi: 10.3389/frhs.2022.1020920. eCollection 2022.

DOI:10.3389/frhs.2022.1020920
PMID:36925859
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10012805/
Abstract

Health care is becoming increasingly unaffordable for both individuals and employers and prices vary in nearly incomprehensible ways that do not correlate with quality. In many areas, consolidation of insurers and providers resulted in market failure that needs policy interventions. With federal gridlock, state policymakers are seeking options for controlling health care costs in markets where competition has failed. In this article, we discuss a spectrum of options that policymakers have to more directly control healthcare prices: (1) establishing a cost-growth benchmark, (2) creating a public option, (3) capping or establishing a default out-of-network payment rate for health care services, (4) creating affordability standards that authorize the insurance commissioner to reject contracts with excessive rate increases, (5) creating global budgets for hospital-based care, (6) capping excessive prices and/or tiering allowed rate updates, and (7) creating a population-based payment model. We provide a roadmap for state policymakers to consider these options, review the experiences with states who have tried these models, and discuss additional design considerations that policymakers should consider with any of these models. In the 1970's and 1980's, during a time of rapid growth in health care prices and spending, states took a decisive leadership role in developing regulatory models to curb the growth in health care costs and improve affordability for their citizens. It is time for states to lead the nation once again in addressing the current health care cost and affordability crisis in the U.S.

摘要

医疗保健对于个人和雇主而言正变得越来越难以负担,而且价格的变化方式几乎令人难以理解,与质量也没有关联。在许多地区,保险公司和医疗服务提供商的合并导致了市场失灵,这需要政策干预。由于联邦政府陷入僵局,州政策制定者正在为竞争失败的市场寻找控制医疗保健成本的办法。在本文中,我们讨论了政策制定者可以用来更直接控制医疗保健价格的一系列选择:(1)设定成本增长基准;(2)创建公共选项;(3)为医疗保健服务设定上限或确定默认的网络外支付费率;(4)制定可负担性标准,授权保险专员拒绝费率过度上涨的合同;(5)为医院护理制定全球预算;(6)限制过高价格和/或对允许的费率更新进行分层;(7)创建基于人群的支付模式。我们为州政策制定者提供了一个路线图,以考虑这些选择,回顾那些尝试过这些模式的州的经验,并讨论政策制定者在采用任何这些模式时应考虑的其他设计因素。在20世纪70年代和80年代,在医疗保健价格和支出快速增长的时期,各州在开发监管模式以抑制医疗保健成本增长并提高其公民的可负担性方面发挥了决定性的领导作用。现在是各州再次引领全国应对美国当前的医疗保健成本和可负担性危机的时候了。